Medtronic 780G pump
Selected indexed studies
- In Silico Evaluation of the Medtronic 780G System While Using the GS3 and Its Calibration-Free Successor, the G4S Sensor. (Ann Biomed Eng, 2023) [PMID:36125605]
- Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus. (Nutr Metab Cardiovasc Dis, 2022) [PMID:35599092]
- Comparison of Metabolic Control in Children and Adolescents Treated with Insulin Pumps. (Children (Basel), 2024) [PMID:39062288]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- In Silico Evaluation of the Medtronic 780G System While Using the GS3 and Its Calibration-Free Successor, the G4S Sensor. (2023) pubmed
- Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus. (2022) pubmed
- Comparison of Metabolic Control in Children and Adolescents Treated with Insulin Pumps. (2024) pubmed
- Combining an Electrochemical Continuous Glucose Sensor With an Insulin Delivery Cannula: A Feasibility Study. (2024) pubmed
- Physical activity and hybrid closed loop technology in adults with type 1 diabetes mellitus - what are the challenges experienced by the users and how are these met? A qualitative interview study. (2026) pubmed
- Hybrid closed Loop improved glucose control compared to sensor-augmented pumps in outpatients with type 1 diabetes in real-life conditions with telehealth monitoring. (2022) pubmed
- Real-world glycaemic outcomes observed with the use of Medtronic 780G, Tandem Control-IQ and Omnipod 5 automated insulin delivery systems. (2026) pubmed
- Switching from treatment with sensor augmented pump to hybrid closed loop system in type 1 diabetes: Impact on glycemic control and neuropsychological tests in the real world. (2023) pubmed
- The Feasibility of an Experimental Hypobaric Simulation to Evaluate the Safety of Closed-Loop Insulin Delivery Systems in Flight-Related Atmospheric Pressure Changes. (2025) pubmed
- Improvements in both glycaemic and inflammatory profile in people with type 1 diabetes using automated insulin delivery systems. (2026) pubmed